1. Home
  2. ORN vs BBOT Comparison

ORN vs BBOT Comparison

Compare ORN & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$8.58

Market Cap

542.0M

Sector

Industrials

ML Signal

HOLD

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

HOLD

Current Price

$3.96

Market Cap

442.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORN
BBOT
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.0M
442.6M
IPO Year
2007
2024

Fundamental Metrics

Financial Performance
Metric
ORN
BBOT
Price
$8.58
$3.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$16.25
★ $24.00
AVG Volume (30 Days)
369.3K
★ 638.1K
Earning Date
04-28-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 220.00
99.93
EPS
★ 0.12
N/A
Revenue
★ $852,260,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$7.83
N/A
P/E Ratio
$71.00
★ N/A
Revenue Growth
★ 7.01
N/A
52 Week Low
$8.08
$3.90
52 Week High
$17.40
$14.87

Technical Indicators

Market Signals
Indicator
ORN
BBOT
Relative Strength Index (RSI) 33.38 16.12
Support Level N/A N/A
Resistance Level $9.75 $9.53
Average True Range (ATR) 0.29 0.55
MACD 0.03 -0.18
Stochastic Oscillator 18.18 1.26

Price Performance

Historical Comparison
ORN
BBOT

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Share on Social Networks: